2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy25 November 2008/in 2008, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2008-11-25 16:44:212016-11-25 16:44:392008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy
2008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent15 November 2008/in 2008, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products2008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent https://astx.com/wp-content/uploads/2019/11/logo_white.png 0 0 webadmin https://astx.com/wp-content/uploads/2019/11/logo_white.png webadmin2008-11-15 16:44:442016-11-25 16:45:042008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent
